Healthcare

According to a new market report published by Lucintel, the future of the gene expression market looks promising with opportunities in drug discovery & development, clinical diagnostic, and biotechnology & microbiology applications. The global gene expression market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are decreasing cost of sequencing, technological advancements, rising prevalence of cancer, availability of government funding, novel technologies to aid gene expression studies, growing application areas of gene expression, and availability of gene expression databases.

Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. In this market, consumables (kits and reagents and DNA chips), instruments (PCR, NGS, DNA microarray, and others), and services (gene expression profiling services (sequencing services and other services) and bioinformatics solutions) are the major product and service segments. Lucintel forecasts that kits and reagents will remain the largest product and service segment over the forecast period, driven by higher usage of these products, low price, launch of novel kits and reagents with enhanced efficiency, and rising demand for better data interpretation & visualization.

Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period due to utilization of gene expression analysis products and services to achieve clinical research goals, increasing focus on developing targeted therapies, and increasing in the demand for gene expression analysis services offered by CROs.

North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a substantial number of well-established players in the region, increased focus on advanced healthcare, government support to initiatives that promote precision medicines, and high investments in genomic research.

Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche, GE Healthcare, Pacific Biosciences of California, Agilent Technologies, QIAGEN, Oxford Gene Technologies, and Eurofins Scientific are among the major suppliers in the global gene expression market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global gene expression market by product and service, process, capacity, technique, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Gene Expression Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global gene expression market by product and service, process, capacity, technique, application, end user, and region as follows:

By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Consumables
  
  
  
  • 
    Kits and Reagents
  
  
  • 
    DNA Chips
  
  
  
  


• 
  Instruments
  
  
  
  • 
    PCR
  
  
  • 
    NGS
  
  
  • 
    DNA Microarray
  
  
  • 
    Others
  
  
  
  


• 
  Services
  
  
  
  • 
    Gene Expression Profiling Services
    
    
    
    • 
      Sequencing Services
    
    
    • 
      Other Services
    
    
    
    
  
  
  • 
    Bioinformatics Solutions
  
  
  
  

 

By Process [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Sample Collection


• 
  Purification


• 
  cDNA Synthesis & Conversion


• 
  PCR Analysis


• 
  Data Analysis & Interpretation

 

By Capacity [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Low- to Mid- Plex


• 
  High-Plex

 

By Technique [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  RNA Expression
  
  
  
  • 
    Northern Blotting
  
  
  • 
    DNA Microarrays
  
  
  • 
    PCR Techniques
  
  
  • 
    RNA-Seq
  
  
  
  


• 
  Promoter Analysis
  
  
  
  • 
    In-vitro Transcription/Nuclear Run-On Assays
  
  
  • 
    Gel Shift Assays
  
  
  • 
    Chromatin Immunoprecipitation (ChIP)
  
  
  
  


• 
  Protein Expression & Posttranslational Modification Analysis
  
  
  
  • 
    Western Blotting
  
  
  • 
    2-D Gel Electrophoresis
  
  
  • 
    Immunoassays
  
  
  • 
    Mass Spectrometry
  
  
  
  

 

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Drug Discovery & Development


• 
  Clinical Diagnostics


• 
  Biotechnology & Microbiology


• 
  Others

 

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  Pharmaceutical and Biotech companies


• 
  Academic Institutes and Research Centers


• 
  Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

• 
  North America

• 
  United States


• 
  Canada


• 
  Mexico

• 
  Europe

• 
  United Kingdom


• 
  Spain


• 
  Germany


• 
  France

• 
  Asia Pacific

• 
  China


• 
  India


• 
  Japan

• 
  The Rest of the World

• 
  Brazil

 

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.